Subscribe to RSS
DOI: 10.1055/s-0043-1770917
Placenta Accreta Spectrum Disorders: Current Recommendations from the Perspective of Antenatal Imaging
The Burden of a Previous Uterine Scar
Cesarean section (CS) is the most commonly performed surgical procedure in the United States (more than a million surgeries per year) and one of the most frequently performed procedures worldwide.[1] Although CS is a potentially life-saving procedure when correctly indicated, its worldwide use has steadily increased over the last decades (currently 21.1% globally, ranging from 5% in sub-Saharan Africa to 42.8% in Latin America and the Caribbean). Moreover, it will continue increasing worldwide (2030 projection: 28.5% globally, ranging from 7.1% in sub-Saharan Africa to 63.4% in Eastern Asia).[2] Dominican Republic, Brazil, Cyprus, Egypt and Turkey are the worldwide leaders, with CS rates ranging from 58.1% to 50.8%, respectively, which points to a worrying trend towards overmedicalization of childbirth and overuse of CS.[2] Other surgical procedures such as dilation, curettage, myomectomy, and surgical hysteroscopy are less frequent than CS. Still, due to the trend towards more advanced maternal age, the number of pregnant women previously submitted to these procedures also tends to increase. These data point to a growing number of pregnancies in surgically manipulated uteruses.
Pregnant women with previous uterine scars are at risk for increased morbimortality. Complications such as placenta previa, spontaneous uterine rupture, uterine dehiscence (with or without placental intrusion), cesarean scar pregnancy (CSP) and placenta accreta spectrum disorders (PAS) are associated with potentially life-threatening uterine bleeding, extra-uterine lesions and preterm delivery ([Figure 1]).[3]
A previous CS increases up to 60% the risk for placenta previa at delivery (approximate incidence: 0.3-2%), with a dose-response pattern based on the number of previous surgeries.[4] The incidence of uterine rupture was estimated as being 5.1 per 10,000 in scarred and 0.8 per 10,000 in unscarred uteruses, with 72% occurring during spontaneous labor.[5] A retrospective cohort of 169,356 pregnancies in a high-risk tertiary hospital reported 0.1% cases of uterine disruption - 83% dehiscence and 17% complete uterine ruptures - the latter significantly more associated with adverse perinatal outcomes. All these pregnancies had previous CS, mainly by low transverse incisions (60%).[6] CSP was estimated to range from 1:1,800 to 1:2,216 pregnancies, 52% in women with only one previous CS.[7] A systematic review and meta-analysis reported that the median prevalence of placenta previa with PAS was 0.07%, with an incidence of PAS in women with placenta previa of 11.1%. More than 90% of PAS cases occurred in women with a previous CS and low-lying/placenta previa.[8] Based on its mounting incidence and potential impact on maternal-fetal mortality, current strategies for mitigating the risks of CSP/PAS must be discussed.
Publication History
Article published online:
21 July 2023
© 2023. Federação Brasileira de Ginecologia e Obstetrícia. This is an open access article published by Thieme under the terms of the Creative Commons Attribution License, permitting unrestricted use, distribution, and reproduction so long as the original work is properly cited. (https://creativecommons.org/licenses/by/4.0/)
Thieme Revinter Publicações Ltda.
Rua do Matoso 170, Rio de Janeiro, RJ, CEP 20270-135, Brazil
-
References
- 1 Sung S, Mahdy H. Cesarean section. In: StatPearls [Internet]. Treasure Island: StatPearls Publishing; 2022 [cited 2023 Feb 12]. Available from: https://www.ncbi.nlm.nih.gov/books/NBK546707/
- 2 Betran AP, Ye J, Moller AB, Souza JP, Zhang J. Trends and projections of caesarean section rates: global and regional estimates. BMJ Glob Health 2021; 6 (06) e005671 DOI: 10.1136/bmjgh-2021-005671.
- 3 Deneux-Tharaux C. Utérus cicatriciel : aspects épidémiologiques. J Gynecol Obstet Biol Reprod (Paris) 2012; 41 (08) 697-707 DOI: 10.1016/j.jgyn.2012.09.022.
- 4 Ananth CV, Smulian JC, Vintzileos AM. The association of placenta previa with history of cesarean delivery and abortion: a metaanalysis. Am J Obstet Gynecol 1997; 177 (05) 1071-1078 DOI: 10.1016/s0002-9378(97)70017-6.
- 5 Zwart JJ, Richters JM, Öry F, de Vries JI, Bloemenkamp KW, van Roosmalen J. Uterine rupture in The Netherlands: a nationwide population-based cohort study. BJOG 2009; 116 (08) 1069-1078 , discussion 1078–1080 DOI: 10.1111/j.1471-0528.2009.02136.x.
- 6 Figueiró-Filho EA, Gomez JM, Farine D. Risk Factors associated with uterine rupture and dehiscence: a cross-sectional Canadian study. Rev Bras Ginecol Obstet 2021; 43 (11) 820-825 DOI: 10.1055/s-0041-1739461.
- 7 Rotas MA, Haberman S, Levgur M. Cesarean scar ectopic pregnancies: etiology, diagnosis, and management. Obstet Gynecol 2006; 107 (06) 1373-1381 DOI: 10.1097/01.AOG.0000218690.24494.ce.
- 8 Jauniaux E, Grønbeck L, Bunce C, Langhoff-Roos J, Collins SL. Epidemiology of placenta previa accreta: a systematic review and meta-analysis. BMJ Open 2019; 9 (11) e031193 DOI: 10.1136/bmjopen-2019-031193.
- 9 Einerson BD, Comstock J, Silver RM, Branch DW, Woodward PJ, Kennedy A. Placenta accreta spectrum disorder: uterine dehiscence, not placental invasion. Obstet Gynecol 2020; 135 (05) 1104-1111 DOI: 10.1097/AOG.0000000000003793.
- 10 Jauniaux E, Jurkovic D, Hussein AM, Burton GJ. New insights into the etiopathology of placenta accreta spectrum. Am J Obstet Gynecol 2022; 227 (03) 384-391 DOI: 10.1016/j.ajog.2022.02.038.
- 11 Timor-Tritsch IE, Monteagudo A, Cali G. et al. Cesarean scar pregnancy and early placenta accreta share common histology. Ultrasound Obstet Gynecol 2014; 43 (04) 383-395 DOI: 10.1002/uog.13282.
- 12 Jauniaux E, Hecht JL, Elbarmelgy RA, Elbarmelgy RM, Thabet MM, Hussein AM. Searching for placenta percreta: a prospective cohort and systematic review of case reports. Am J Obstet Gynecol 2022; 226 (06) 837.e1-837.e13 DOI: 10.1016/j.ajog.2021.12.030.
- 13 Einerson BD, Kennedy A, Silver RM, Branch DW, Comstock J, Woodward PJ. Ultrasonography of the explanted uterus in placenta accreta spectrum. Obstet Gynecol 2023; 141 (03) 544-554 DOI: 10.1097/AOG.0000000000005075.
- 14 Luke RK, Sharpe JW, Greene RR. Placenta accreta: the adherent or invasive placenta. Am J Obstet Gynecol 1966; 95 (05) 660-668 DOI: 10.1016/s0002-9378(16)34741-x.
- 15 Jauniaux E, Ayres-de-Campos D, Langhoff-Roos J, Fox KA. Collins S. FIGO Placenta Accreta Diagnosis and Management Expert Consensus Panel. FIGO classification for the clinical diagnosis of placenta accreta spectrum disorders. Int J Gynaecol Obstet 2019; 146 (01) 20-24 DOI: 10.1002/ijgo.12761.
- 16 Aalipour S, Salmanian B, Fox KA. et al. Placenta accreta spectrum: correlation between FIGO clinical classification and histopathologic findings. Am J Perinatol 2023; 40 (02) 149-154 DOI: 10.1055/s-0041-1728834.
- 17 Palacios-Jaraquemada JM, Basanta N, Nieto-Calvache Á, Aryananda RA. Comprehensive surgical staging for placenta accreta spectrum. J Matern Fetal Neonatal Med 2022; 35 (26) 10660-10666 DOI: 10.1080/14767058.2022.215457.
- 18 Palacios-Jaraquemada JM, Fiorillo A, Hamer J, Martínez M, Bruno C. Placenta accreta spectrum: a hysterectomy can be prevented in almost 80% of cases using a resective-reconstructive technique. J Matern Fetal Neonatal Med 2022; 35 (02) 275-282 DOI: 10.1080/14767058.2020.1716715.
- 19 Shamshirsaz AA, Fox KA, Salmanian B. et al. Maternal morbidity in patients with morbidly adherent placenta treated with and without a standardized multidisciplinary approach. Am J Obstet Gynecol 2015; 212 (02) 218.e1-218.e9 DOI: 10.1016/j.ajog.2014.08.019.
- 20 Nieto-Calvache AJ, Palacios-Jaraquemada JM, Vergara-Galliadi LM. et al; Latin American Group for the Study of Placenta Accreta Spectrum. All maternal deaths related to placenta accreta spectrum are preventable: a difficult-to-tell reality. AJOG Glob Rep 2021; 1 (03) 100012 DOI: 10.1016/j.xagr.2021.100012.
- 21 Chandraharan E, Hartopp R, Thilaganathan B, Coutinho CM. How to set up a regional specialist referral service for Placenta Accreta Spectrum (PAS) disorders?. Best Pract Res Clin Obstet Gynaecol 2021; 72: 92-101 DOI: 10.1016/j.bpobgyn.2020.07.007.
- 22 Nieto-Calvache AJ, Palacios-Jaraquemada JM, Aryananda RA. Factors to consider when seeking better results in placenta accreta spectrum. Acta Obstet Gynecol Scand 2021; 100 (10) 1932-1933 DOI: 10.1111/aogs.14214.
- 23 Hobson SR, Kingdom JCP, Windrim RC. et al. Safer outcomes for placenta accreta spectrum disorders: A decade of quality improvement. Int J Gynaecol Obstet 2022; 157 (01) 130-139 DOI: 10.1002/ijgo.13717.
- 24 Nieto-Calvache AJ, Benavides Calvache JP, Sinisterra-Díaz SE, Maya J. Letter to the editor: Implementing research activities, an earmark of placenta accreta spectrum reference centers. Int J Gynaecol Obstet 2022; 159 (01) 330-331 DOI: 10.1002/ijgo.14380.
- 25 Coutinho CM, Noel L, Giorgione V, Marçal LCA, Bhide A, Thilaganathan B. Placenta accreta spectrum disorders and cesarean scar pregnancy screening: are we asking the right questions?. Rev Bras Ginecol Obstet 2021; 43 (05) 347-350 DOI: 10.1055/s-0041-1731301.
- 26 Cali G, Forlani F, Timor-Tritsch IE, Palacios-Jaraquemada J, Minneci G, D'Antonio F. Natural history of Cesarean scar pregnancy on prenatal ultrasound: the crossover sign. Ultrasound Obstet Gynecol 2017; 50 (01) 100-104 DOI: 10.1002/uog.16216.
- 27 Panaiotova J, Tokunaka M, Krajewska K, Zosmer N, Nicolaides KH. Screening for morbidly adherent placenta in early pregnancy. Ultrasound Obstet Gynecol 2019; 53 (01) 101-106 DOI: 10.1002/uog.20104.
- 28 D'Antonio F, Timor-Tritsch IE, Palacios-Jaraquemada J. et al. First-trimester detection of abnormally invasive placenta in high-risk women: systematic review and meta-analysis. Ultrasound Obstet Gynecol 2018; 51 (02) 176-183 DOI: 10.1002/uog.18840.
- 29 Coutinho CM, Giorgione V, Noel L. et al. Effectiveness of contingent screening for placenta accreta spectrum disorders based on persistent low-lying placenta and previous uterine surgery. Ultrasound Obstet Gynecol 2021; 57 (01) 91-96 DOI: 10.1002/uog.23100.
- 30 Timor-Tritsch I, Buca D, Di Mascio D. et al. Outcome of cesarean scar pregnancy according to gestational age at diagnosis: A systematic review and meta-analysis. Eur J Obstet Gynecol Reprod Biol 2021; 258: 53-59 DOI: 10.1016/j.ejogrb.2020.11.036.
- 31 Cali G, Forlani F, Foti F. et al. Diagnostic accuracy of first-trimester ultrasound in detecting abnormally invasive placenta in high-risk women with placenta previa. Ultrasound Obstet Gynecol 2018; 52 (02) 258-264 DOI: 10.1002/uog.19045.
- 32 D'Antonio F, Iacovella C, Bhide A. Prenatal identification of invasive placentation using ultrasound: systematic review and meta-analysis. Ultrasound Obstet Gynecol 2013; 42 (05) 509-517 DOI: 10.1002/uog.13194.
- 33 D'Antonio F, Iacovella C, Palacios-Jaraquemada J, Bruno CH, Manzoli L, Bhide A. Prenatal identification of invasive placentation using magnetic resonance imaging: systematic review and meta-analysis. Ultrasound Obstet Gynecol 2014; 44 (01) 8-16 DOI: 10.1002/uog.13327.
- 34 Jordans IPM, Verberkt C, De Leeuw RA. et al. Definition and sonographic reporting system for Cesarean scar pregnancy in early gestation: modified Delphi method. Ultrasound Obstet Gynecol 2022; 59 (04) 437-449 DOI: 10.1002/uog.24815.
- 35 Jauniaux E, D'Antonio F, Bhide A. et al; Delphi consensus expert panel. Modified Delphi study of ultrasound signs associated with placenta accreta spectrum. Ultrasound Obstet Gynecol 2023; 61 (04) 518-525 DOI: 10.1002/uog.26155.
- 36 Nieto-Calvache AJ, Benavides-Calvache JP, Hidalgo A. et al. Placenta accreta spectrum prenatal diagnosis performance: are ultrasound false-positive results acceptable in limited-resources settings?. Rev Bras Ginecol Obstet 2022; 44 (09) 838-844 DOI: 10.1055/s-0042-1751061.
- 37 Hussein AM, Fox K, Bhide A. et al. The impact of preoperative ultrasound and intraoperative findings on surgical outcomes in patients at high risk of placenta accreta spectrum. BJOG 2023; 130 (01) 42-50 DOI: 10.1111/1471-0528.17286.
- 38 Nieto-Calvache AJ, Aguilera LR. Simulation, a fundamental component of training to treat placenta accreta spectrum. Rev Bras Ginecol Obstet 2022; 44 (12) 1159-1160 DOI: 10.1055/s-0042-1760216.
- 39 Sandlin AT, Magann EF, Whittington JR. et al. Management of pregnancies complicated by placenta accreta spectrum utilizing a multidisciplinary care team in a rural state. J Matern Fetal Neonatal Med 2022; 35 (25) 5964-5969 DOI: 10.1080/14767058.2021.1903425.
- 40 Nieto-Calvache AJ, Palacios-Jaraquemada JM, Vergara-Galliadi LM, Nieto-Calvache AS, Zambrano MA, Burgos-Luna JM. Training facilitated by interinstitutional collaboration and telemedicine: an alternative for improving results in the placenta accreta spectrum. AJOG Glob Rep 2021; 1 (04) 100028 DOI: 10.1016/j.xagr.2021.100028.